
Major changes are afoot in Germany and the UK, the last two European countries with ‘free pricing’ of pharmaceuticals. Governments …
AstraZeneca has defeated a challenge to the US patent on its blockbuster cholesterol drug Crestor. A US District Judge in …
CSL Biotherapies has been sent a letter by the US Food and Drug Administration which indicates that vials of seasonal …
How healthy is your digital engagement strategy? World-class ‘Olympian’, or ‘gasping for breath’? We’ve put together a quick quiz for …
GlaxoSmithKline’s kidney cancer drug Votrient has been forecast as a future leader in a marketplace currently dominated by Pfizer. Analysts …

Janssen-Cilag UK has unveiled the first psoriasis iPhone app – a disease calculator for healthcare professionals treating the chronic skin condition. It …
New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …

The US and India are looking to establish closer ties between their top medical schools. The initiative was one of …
Sanofi-Aventis is to buy TargeGen, a US biopharmaceutical company which develops small molecule kinase inhibitors. The drugs are used to …
The FDA has published draft guidance aimed at alleviating the burden on pharmaceutical companies of notifying the agency of minor …
Takeda has made new two appointments, looking outside the company to fill a brace of executive-level positions. Dr Frank Morich …
The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
Yet more geographic expansion from leading CROs, with Kendle opening an office in India and PRA International announcing a Hungarian …

GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …
For the first time patients are to be paid directly by the NHS to allow them to choose how their …
The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …
Contract development and manufacturing company DPT Laboratories has promoted JJ Feik to senior director of business development. He was previously …
Researchers in the US have developed a new synthetic pathway that could make the development of new pharmaceuticals quicker, cleaner …
Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …